Summary
In a significant market movement during January 2024, Carcinotech was the subject of a vc funding. The transaction achieved a gross valuation of £4,200,000. Leading the round was Investing Women Angels, Alba Equity, Investment Fund for Scotland (IFS), Eos Advisory, Old College Capital, SIS Ventures, Gabriel Investment Syndicate, Maven Capital Partners, Scottish Enterprise, TRICAPITAL.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
Investing Women Angels
Lead Investor / Acquirer
Alba Equity
Lead Investor / Acquirer
Investment Fund for Scotland (IFS)
Lead Investor / Acquirer
Eos Advisory
Lead Investor / Acquirer
Old College Capital
Lead Investor / Acquirer
SIS Ventures
Lead Investor / Acquirer
Gabriel Investment Syndicate
Lead Investor / Acquirer
Maven Capital Partners
Lead Investor / Acquirer
Scottish Enterprise
Lead Investor / Acquirer
TRICAPITAL
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Series A prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in